FDA Drug Safety Communication: Safety Review update of Abacavir and possible increased risk of heart attack
Links shared publicly online about this topic.
- 470total visits
FDA Drug Safety Communication: Safety Review update of Abacavir and possible increased risk of heart attack
fda.gov —
View full resource at fda.gov
Tags: Heart, Heart Disease, Heart Attack, HIV Medication, Drug, Ziagen, Safety
Most Recently Shared on March 2, 2011 at 2:59 am By:
FDA - Safety Review update of Abacavir and possible increased risk of heart attack http://bit.ly/ekjvVV
Ongoing Abacavir Safety Review Finds No Increased Risk of Heart Attack - The Body
thebody.com — “The Food and Drug Administration (FDA) is updating the public about its ongoing safety review of abacavir and a possible increased risk of heart attack. ...” View full resource at thebody.com
Most Recently Shared on March 2, 2011 at 9:00 pm By:
Ongoing Abacavir Safety Review Finds No Increased Risk of Heart Attack http://bit.ly/eu6tkM #hiv #aids #ziagen
FDA Drug Safety Communication: Safety Review Update of Abacavir and Possible Increased Risk of Heart Attack - Drugs.com MedNews
drugs.com — “Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement 03-01-2011 The U.S.” View full resource at drugs.com
Most Recently Shared on March 2, 2011 at 1:14 pm By:
Drugs and Devices OW OW Health
FDA Drug Safety Communication: Safety Review Update of Abacavir and Possible Increased Risk of Heart Attac... http://bit.ly/fTwPDX #drug
Advertisement
